: The AMEDEO Literature Guide

Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Gynecology

Free Subscription

Articles published in Gynecol Oncol
Retrieve available abstracts of 499 articles:
HTML format
Text format

Single Articles

March 2010

JUANG CM , Yen MS, Chao KC
Reply to Dr. Markman on "Importance of delivered cycles and nomogram for intraperitoneal chemotherapy in ovarian cancer"
Gynecol Oncol. 2010.
PubMed Text format Related articles

HUANG YW , Luo J, Weng YI, Mutch DG, et al
Promoter hypermethylation of CIDEA, HAAO and RXFP3 associated with microsatellite instability in endometrial carcinomas.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

DESPIERRE E , Lambrechts D, Neven P, Amant F, et al
The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

QUINT KD , de Koning MN, van Doorn LJ, Quint WG, et al
HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

ILLADES-AGUIAR B , Alarcon-Romero LD, Antonio-Vejar V, Zamudio-Lopez N, et al
Prevalence and distribution of human papillomavirus types in cervical cancer, squamous intraepithelial lesions, and with no intraepithelial lesions in women from Southern Mexico.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

TERRY K , McGrath M, Lee IM, Buring J, et al
Genetic variation in CYP11A1 and StAR in relation to endometrial cancer risk.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

KEHOE SM , Zivanovic O, Ferguson SE, Barakat RR, et al
Clinicopathologic features of bone metastases and outcomes in patients with primary endometrial cancer.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

Abstracts Presented for the 41st Annual Meeting of the Society of Gynecologic Oncologists, Annual Meeting of the Society of Gynecologic Oncologists,10-17 March 2010.
Gynecol Oncol. 2010;116.
PubMed Text format Related articles

DE MARZI P , Frigerio L, Cipriani S, Parazzini F, et al
Adjuvant treatment with concomitant radiotherapy and chemotherapy in high-risk endometrial cancer: a clinical experience.
Gynecol Oncol. 2010;116:408-12.
PubMed Text format Related articles Abstract available

ABU-RUSTUM NR , Zhou Q, Gomez JD, Alektiar KM, et al
A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer care.
Gynecol Oncol. 2010;116:399-403.
PubMed Text format Related articles Abstract available

PIERALLI A , Bussani C, Andersson KL, Mattei A, et al
Appendix to: "PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO(2) conization for high-grade cervical intraepithelial neoplasia".
Gynecol Oncol. 2010;116:586-7.
PubMed Text format Related articles

VAN DEN AKKER PA , Aalders AL, Snijders MP, Kluivers KB, et al
Evaluation of the Risk of Malignancy Index in daily clinical management of adnexal masses.
Gynecol Oncol. 2010;116:384-8.
PubMed Text format Related articles Abstract available

DEL PRIORE G , Gudipudi DK, Montemarano N, Restivo AM, et al
Oral diindolylmethane (DIM): pilot evaluation of a nonsurgical treatment for cervical dysplasia.
Gynecol Oncol. 2010;116:464-7.
PubMed Text format Related articles Abstract available

O'CEARBHAILL R , Zhou Q, Iasonos A, Soslow RA, et al
Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors.
Gynecol Oncol. 2010;116:424-9.
PubMed Text format Related articles Abstract available

RADZISZEWSKI J , Kowalewska M, Jedrzejczak T, Kozlowicz-Gudzinska I, et al
The accuracy of the sentinel lymph node concept in early stage squamous cell vulvar carcinoma.
Gynecol Oncol. 2010;116:473-7.
PubMed Text format Related articles Abstract available

PAVLAKIS K , Messini I, Yiannou P, Chrissanthakis D, et al
A pre-tailored panel of antibodies in the study of cervical mesonephric remnants.
Gynecol Oncol. 2010;116:468-72.
PubMed Text format Related articles Abstract available

LAN C , Li Y, He J, Liu J, et al
Placental site trophoblastic tumor: lymphatic spread and possible target markers.
Gynecol Oncol. 2010;116:430-7.
PubMed Text format Related articles Abstract available

SHIH KK , Chi DS, Barakat RR, Leitao MM Jr, et al
Beyond tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Gynecol Oncol. 2010;116:364-9.
PubMed Text format Related articles Abstract available

CREASMAN WT , Mutch DE, Herzog TJ
ASTEC lymphadenectomy and radiation therapy studies: are conclusions valid?
Gynecol Oncol. 2010;116:293-4.
PubMed Text format Related articles

GONZALEZ BOSQUET J , Terstriep SA, Cliby WA, Brown-Jones M, et al
The impact of multi-modal therapy on survival for uterine carcinosarcomas.
Gynecol Oncol. 2010;116:419-23.
PubMed Text format Related articles Abstract available

NUGENT EK , Case AS, Hoff JT, Zighelboim I, et al
Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors.
Gynecol Oncol. 2010;116:438-41.
PubMed Text format Related articles Abstract available

MILLER DA , Richardson S, Grigsby PW
A new method of anatomically conformal vaginal cuff HDR brachytherapy.
Gynecol Oncol. 2010;116:413-8.
PubMed Text format Related articles Abstract available

February 2010

SHIH KK , Chi DS, Barakat RR, Leitao MM Jr, et al
Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: An updated series.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

PILS D , Wittinger M, Petz M, Gugerell A, et al
BAMBI is overexpressed in ovarian cancer and co-translocates with Smads into the nucleus upon TGF-ss treatment.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

HUH WK , Sill MW, Darcy KM, Elias KM, et al
Efficacy and safety of imatinib mesylate (Gleevec(R)) and immunohistochemical expression of c-Kit and PDGFR-beta in a Gynecologic Oncology Group Phase Il Trial in women with recurrent or persistent carcinosarcomas of the uterus.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

POLLOCK J
Letter to the editor in response to "Stage 1, grade 3 endometrioid adenocarcinoma of the endometrium: An analysis of clinical outcomes and patterns of recurrence"
Gynecol Oncol. 2010.
PubMed Text format Related articles

ROSE PG , Tian C, Bookman MA
Assessment of tumor response as a surrogate endpoint of survival in recurrent/platinum-resistant ovarian carcinoma: A Gynecologic Oncology Group study.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

SECKL MJ , Savage PM, Hancock BW, Berkowitz RS, et al
"Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases"
Gynecol Oncol. 2010.
PubMed Text format Related articles

CHENG L , Lu W, Kulkarni B, Pejovic T, et al
Analysis of chemotherapy response programs in ovarian cancers by the next-generation sequencing technologies.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

ROSE PG , Ali S, Whitney CW, Lanciano R, et al
Impact of hydronephrosis on outcome of stage IIIB cervical cancer patients with disease limited to the pelvis, treated with radiation and concurrent chemotherapy: A Gynecologic Oncology Group study.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

MINIG L , Zanagnolo V, Maggioni A
Robotic approach for cervical cancer: Comparison with laparotomy. A case control study.
Gynecol Oncol. 2010.
PubMed Text format Related articles

SANTIN AD
Letter to the Editor referring to the manuscript entitled: "Phase II trial of trastuzumab in women with advanced or recurrent HER-positive endometrial carcinoma: a Gynecologic Oncology Group study" recently reported by Fleming et al., (Gynecol Oncol.,
Gynecol Oncol. 2010.
PubMed Text format Related articles

HAZEWINKEL MH , Sprangers MA, van der Velden J, van der Vaart CH, et al
Long-term cervical cancer survivors suffer from pelvic floor symptoms: A cross-sectional matched cohort study.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

DARLIN L , Persson J, Bossmar T, Lindahl B, et al
The sentinel node concept in early cervical cancer performs well in tumors smaller than 2 cm.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

MARKMAN M
"Clinical benefit rate" in phase 2 gynecologic cancer trials: Implying more than the data support?
Gynecol Oncol. 2010.
PubMed Text format Related articles

GIEN LT , Covens A
Fertility-sparing options for early stage cervical cancer.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

ZHOU X , Chen X, Hu L, Han S, et al
Polymorphisms involved in the miR-218-LAMB3 pathway and susceptibility of cervical cancer, a case-control study in Chinese women.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

LIANG Y , Wang S, Gu M
Should epidural analgesia be dismissed in gynecologic oncology surgery?
Gynecol Oncol. 2010.
PubMed Text format Related articles

CARTER J , Raviv L, Appollo K, Baser RE, et al
A pilot study using the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) as a clinical care tool to identify lower extremity lymphedema in gynecologic cancer survivors.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

CANTRELL LA , Mendivil A, Gehrig PA, Boggess JF, et al
Survival outcomes for women undergoing type III robotic radical hysterectomy for cervical cancer: A 3-year experience.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

RESNICK KE , Frankel WL, Morrison CD, Fowler JM, et al
Mismatch repair status and outcomes after adjuvant therapy in patients with surgically staged endometrial cancer.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

ANSENBERGER K , Richards C, Zhuge Y, Barua A, et al
Decreased severity of ovarian cancer and increased survival in hens fed a flaxseed-enriched diet for 1 year.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

PARADISI R , Fabbri R, Magnani V, Battaglia C, et al
A new simple technique of laparoscopic temporary ovarian suspension in addition to ovarian cryopreservation for women prior to posterior pelvic radiation.
Gynecol Oncol. 2010.
PubMed Text format Related articles

SERT MB
Comparison between robot-assisted laparoscopic radical hysterectomy (RRH) and abdominal radical hysterectomy (ARH): A case control study from EIO/Milan.
Gynecol Oncol. 2010.
PubMed Text format Related articles

TANNER EJ , Chi DS, Eisenhauer EL, Diaz-Montes TP, et al
Surveillance for the detection of recurrent ovarian cancer: Survival impact or lead-time bias?
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

MARKMAN M
"Importance of delivered cycles and nomogram for intraperitoneal chemotherapy in ovarian cancer"
Gynecol Oncol. 2010.
PubMed Text format Related articles

KOHORN EI
Letter to the Editor with Comments on Article by Cole and Muller entitled "Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases"
Gynecol Oncol. 2010.
PubMed Text format Related articles

YIGIT R , Massuger LF, Figdor CG, Torensma R, et al
Ovarian cancer creates a suppressive microenvironment to escape immune elimination.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

CARDENAS-GOICOECHEA J , Adams S, Bhat SB, Randall TC, et al
Surgical outcomes of robotic-assisted surgical staging for endometrial cancer are equivalent to traditional laparoscopic staging at a minimally invasive surgical center.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

LOU E , Hensley ML, Lassman A, Aghajanian C, et al
Paraneoplastic opsoclonus-myoclonus syndrome secondary to immature ovarian teratoma.
Gynecol Oncol. 2010.
PubMed Text format Related articles

EISENKOP SM
Total laparoscopic hysterectomy with pelvic/aortic lymph node dissection for endometrial cancer-a consecutive series without case selection and comparison to laparotomy.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

HELLEMAN J , Smid M, Jansen MP, van der Burg ME, et al
Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: The big picture.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

CUZICK J
Long-term cervical cancer prevention strategies across the globe.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

HAYES MP , Ellenson LH
Molecular alterations in uterine serous carcinoma.
Gynecol Oncol. 2010;116:286-9.
PubMed Text format Related articles Abstract available

HARRY VN
Novel imaging techniques as response biomarkers in cervical cancer.
Gynecol Oncol. 2010;116:253-61.
PubMed Text format Related articles Abstract available

PAUTIER P , Joly F, Kerbrat P, Bougnoux P, et al
Phase II study of gefitinib in combination with paclitaxel (P) and carboplatin (C) as second-line therapy for ovarian, tubal or peritoneal adenocarcinoma (1839IL/0074).
Gynecol Oncol. 2010;116:157-62.
PubMed Text format Related articles Abstract available

CAPO-CHICHI CD , Yeasky TM, Heiber JF, Wang Y, et al
Explicit targeting of transformed cells by VSV in ovarian epithelial tumor-bearing Wv mouse models.
Gynecol Oncol. 2010;116:269-75.
PubMed Text format Related articles Abstract available

ROCHE MR , Rudd PJ, Krasner CN, Matulonis UA, et al
Phase II trial of GM-CSF in women with asymptomatic recurrent mullerian tumors.
Gynecol Oncol. 2010;116:168-72.
PubMed Text format Related articles Abstract available

January 2010

MAY T , Virtanen C, Sharma M, Milea A, et al
Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

NIMEIRI HS , Oza AM, Morgan RJ, Huo D, et al
A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: A trial of the Chicago, PMH, and California Phase II Consortia.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

PANDIT-TASKAR N , Gemignani ML, Lyall A, Larson SM, et al
Single photon emission computed tomography SPECT-CT improves sentinel node detection and localization in cervical and uterine malignancy.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

SEAMON LG , Fowler JM, Cohn DE
Lymphadenectomy for endometrial cancer: The controversy.
Gynecol Oncol. 2010.
PubMed Text format Related articles

MASSAD LS , Evans CT, Wilson TE, Goderre JL, et al
Knowledge of cervical cancer prevention and human papillomavirus among women with HIV.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

MERCADO C , Zingmond D, Karlan BY, Sekaris E, et al
Quality of care in advanced ovarian cancer: The importance of provider specialty.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

BYRON SA , Gartside MG, Wellens CL, Goodfellow PJ, et al
FGFR2 mutations are rare across histologic subtypes of ovarian cancer.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

JI J , Zheng PS
Activation of mTOR signaling pathway contributes to survival of cervical cancer cells.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

VICUS D , Beiner ME, Klachook S, Le LW, et al
Pure dysgerminoma of the ovary 35 years on: A single institutional experience.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

DI GIORGIO A , Cardi M, Sammartino P
Peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian peritoneal carcinomatosis: An argued role.
Gynecol Oncol. 2010.
PubMed Text format Related articles

ZHANG Y , Liu Z, Yu X, Zhang X, et al
The association between metabolic abnormality and endometrial cancer: A large case-control study in China.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

VILLAVICENCIO A , Aguilar G, Arguello G, Dunner C, et al
The effect of overweight and obesity on proliferation and activation of AKT and ERK in human endometria.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

ROB L , Pluta M, Robova H
Less radical surgery than radical hysterectomy in early stage cervical cancer - A pilot study.
Gynecol Oncol. 2010.
PubMed Text format Related articles

DRENBERG CD , Saunders BO, Wilbanks GD, Chen R, et al
Urinary angiostatin levels are elevated in patients with epithelial ovarian cancer.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

PARK JY , Kim DY, Kim JH, Kim YM, et al
Further stratification of risk groups in patients with lymph node metastasis after radical hysterectomy for early-stage cervical cancer.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

ROSE SL , Kunnimalaiyaan M, Drenzek J, Seiler N, et al
Notch 1 signaling is active in ovarian cancer.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

JOBSEN JJ , Ten Cate LN, Lybeert ML, van der Steen-Banasik EM, et al
The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

DANGSUWAN P , Manchana T
Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

WOELBER L , Mueller V, Eulenburg C, Schwarz J, et al
Serum carbonic anhydrase IX during first-line therapy of ovarian cancer.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

WAHL H , Daudi S, Kshirsagar M, Griffith K, et al
Expression of metabolically targeted biomarkers in endometrial carcinoma.
Gynecol Oncol. 2010;116:21-7.
PubMed Text format Related articles Abstract available

RASOOL N , Fader AN, Seamon L, Neubauer NL, et al
Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrence.
Gynecol Oncol. 2010;116:10-4.
PubMed Text format Related articles Abstract available

CIDON EU
Sexual problems after breast cancer: the underreported symptoms.
Gynecol Oncol. 2010;116:147.
PubMed Text format Related articles

December 2009

MARKMAN M , Moon J, Wilczynski S, Lopez AM, et al
Single agent carboplatin versus carboplatin plus pegylated liposomal doxorubicin in recurrent ovarian cancer: Final survival results of a SWOG (S0200) phase 3 randomized trial.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

RISUM S , Hogdall C, Loft A, Berthelsen AK, et al
Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer?
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MARVERTI G , Ligabue A, Guerrieri D, Paglietti G, et al
Spermidine/spermine N1-acetyltranferase modulation by novel folate cycle inhibitors in cisplatin-sensitive and -resistant human ovarian cancer cell lines.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

WALSH CS , Blum A, Walts A, Alsabeh R, et al
Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

ZHAO Y , Zong ZH, Xu HM
RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

ZIVANOVIC O , Sima CS, Iasonos A, Hoskins WJ, et al
The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

DE LA MOTA J , Thomas MB, Micaily B, Espaillat-Rijo L, et al
Polyostotic fibrous dysplasia mimicking bone metastases in a patient with advanced-stage cervical cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles

ZIGHELBOIM I , Kizer N, Taylor NP, Case AS, et al
"Surgical Apgar Score" predicts postoperative complications after cytoreduction for advanced ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

BARNETT JC , Bean SM, Whitaker RS, Kondoh E, et al
Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotype.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

LEE EJ , Kim TJ, Kim DS, Choi CH, et al
p53 alteration independently predicts poor outcomes in patients with endometrial cancer: A clinicopathologic study of 131 cases and literature review.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

FANFANI F , Fagotti A, Gallotta V, Ercoli A, et al
Upper abdominal surgery in advanced and recurrent ovarian cancer: Role of diaphragmatic surgery.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SKRET-MAGIERLO J , Narog M, Kruczek A, Kluza R, et al
Radical hysterectomy during the transition period from traditional to nerve-sparing technique.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

DIAZ JP , Tew WP, Zivanovic O, Konner J, et al
Incidence and management of bevacizumab-associated gastrointestinal perforations in patients with recurrent ovarian carcinoma.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

LEE YY , Choi CH, Kim CJ, Song TJ, et al
Glucose as a prognostic factor in non-diabetic women with locally advanced cervical cancer (IIB-IVA).
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

HSU WC , Chung NN, Chen YC
In response to "Comparison of surgery or radiotherapy on complications and quality of life in patients with the stage IB and IIA uterine cervical cancer"
Gynecol Oncol. 2009.
PubMed Text format Related articles

SAED GM , Ali-Fehmi R, Jiang ZL, Fletcher NM, et al
Myeloperoxidase serves as a redox switch that regulates apoptosis in epithelial ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

ESTAPE R , Lambrou N
Robotic radical hysterectomy for cervical cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles

DUIKER EW , van der Zee AG, de Graeff P, Boersma-van Ek W, et al
The extrinsic apoptosis pathway and its prognostic impact in ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

LI AJ
Application of a risk scoring system to predict surgical adverse events in the management of epithelial ovarian cancers.
Gynecol Oncol. 2009;115:323-4.
PubMed Text format Related articles

IVANSSON EL , Juko-Pecirep I, Gyllensten UB
Interaction of immunological genes on chromosome 2q33 and IFNG in susceptibility to cervical cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

OSKAY-OZCELIK G , Chekerov R, Sommer H, Keil E, et al
Sequential chemotherapy with carboplatin followed by weekly paclitaxel in advanced ovarian cancer: Results of a multicenter phase II study of the northeastern German society of gynecological oncology.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

LESNOCK JL , Richard SD, Zorn KK, Krivak TC, et al
Completion of intraperitoneal chemotherapy in advanced ovarian cancer and catheter-related complications.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

November 2009

GADDUCCI A , Cosio S, Zola P, Sostegni B, et al
The clinical outcome of epithelial ovarian cancer patients with apparently isolated lymph node recurrence: A multicenter retrospective Italian study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

TSOLAKIDIS D , Amant F, Van Gorp T, Leunen K, et al
Diaphragmatic surgery during primary debulking in 89 patients with stage IIIB-IV epithelial ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

NEZHAT F , Cho J, Chuang L
Response to "A case matched analysis of robotic radical hysterectomy with lymphadenectomy compared with laparoscopy and laparotomy"
Gynecol Oncol. 2009.
PubMed Text format Related articles

TAYLOR DD , Atay S, Metzinger DS, Gercel-Taylor C, et al
Characterization of humoral responses of ovarian cancer patients: Antibody subclasses and antigenic components.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

ANDERSEN MR , Goff BA, Lowe KA, Scholler N, et al
Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

DIAZ JP , Abu-Rustum NR, Sonoda Y, Downey RJ, et al
Video-assisted thoracic surgery (VATS) evaluation of pleural effusions in patients with newly diagnosed advanced ovarian carcinoma can influence the primary management choice for these patients.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

CHAN JK , Tian C, Fleming GF, Monk BJ, et al
The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: An exploratory analysis of a Gynecologic Oncology Group study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MCCLOSKEY SA , Tchabo NE, Malhotra HK, Odunsi K, et al
Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

CHAN JK , Tian C, Teoh D, Monk BJ, et al
Survival after recurrence in early-stage high-risk epithelial ovarian cancer: A Gynecologic Oncology Group study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

LAMBAUDIE E , Narducci F, Leblanc E, Bannier M, et al
Robotically-assisted laparoscopic anterior pelvic exenteration for recurrent cervical cancer: Report of three first cases.
Gynecol Oncol. 2009.
PubMed Text format Related articles

O'CEARBHAILL R , Zhou Q, Iasonos A, Hensley ML, et al
The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatment.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

RAMIREZ PT , Schmeler KM, Malpica A, Soliman PT, et al
Safety and feasibility of robotic radical trachelectomy in patients with early-stage cervical cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

KUO DY , Blank SV, Christos PJ, Kim M, et al
Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: A New York Cancer Consortium Study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

KHALIL I , Brewer MA, Neyarapally T, Runowicz CD, et al
The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

NAM EJ , Yun MJ, Oh YT, Kim JW, et al
Diagnosis and staging of primary ovarian cancer: Correlation between PET/CT, Doppler US, and CT or MRI.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

GNANAMONY M , Peedicayil A, Subhashini J, Ram TS, et al
Detection and quantitation of HPV 16 and 18 in plasma of Indian women with cervical cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

KNOL HM , Arts HJ, Reyners AK
Spontaneous disappearance of suspected intrapulmonary metastases after hysterectomy in a patient with a complete hydatiform mole.
Gynecol Oncol. 2009.
PubMed Text format Related articles

AUNER V , Sehouli J, Oskay-Oezcelik G, Horvat R, et al
ABC transporter gene expression in benign and malignant ovarian tissue.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

ROCERETO TF , Brady WE, Shahin MS, Hoffman JS, et al
A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: A gynecologic oncology group study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

DUSKA LR , Garrett L, Henretta M, Ferriss JS, et al
When 'never-events' occur despite adherence to clinical guidelines: The case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

GRAY HJ , Shah CA, Swensen RE, Tamimi HK, et al
Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

LIAO SY , Darcy KM, Randall LM, Tian C, et al
Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

GARG G , Shah JP, Toy EP
Comparison of surgery or radiotherapy on complications and quality of life in patients with the stage IB and IIA uterine cervical cancer (Gynecol Oncol Oct 2009; 115(1):41-45).
Gynecol Oncol. 2009.
PubMed Text format Related articles

O'DONNELL JD , Linger RJ, Kruk PA
BRCA1 185delAG mutant protein, BRAt, up-regulates maspin in ovarian epithelial cells.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

CIBULA D , Velechovska P, Slama J, Fischerova D, et al
Late morbidity following nerve-sparing radical hysterectomy.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

BROOKS R , Kizer N, Nguyen L, Jaishuen A, et al
Polymorphisms in MMP9 and SIPA1 are associated with increased risk of nodal metastases in early-stage cervical cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MCKENZIE ND , Kobetz EN, Hnatyszyn J, Twiggs LB, et al
Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

GEHRIG PA , Bae-Jump VL
Promising novel therapies for the treatment of endometrial cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

WINER I , Buckanovich RJ
A case of progressive mucinous ovarian cancer of low malignant potential responsive to biologic therapy with Bevacizumab.
Gynecol Oncol. 2009.
PubMed Text format Related articles

MINIG L , Trimble EL, Birrer MJ, Kim KY, et al
NIH and NCI support for development of novel therapeutics in gynecologic cancer: A user's guide.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

LIM MC , Lee HS, Seo SS, Kim MS, et al
Pathologic diagnosis and resection of suspicious thoracic metastases in patients with cervical cancer through thoracotomy or video-assisted thoracic surgery.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

JOLY F , Sevin E, Lortholary A, Priou F, et al
Association of pegylated liposomal doxorubicin and ifosfamide in early recurrent ovarian cancer patients: A Multicenter Phase II Trial.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

NELSON BH
IDO and outcomes in ovarian cancer.
Gynecol Oncol. 2009;115:179-80.
PubMed Text format Related articles

BALASUBRAMANI L , Brown BH, Healey J, Tidy JA, et al
The detection of cervical intraepithelial neoplasia by electrical impedance spectroscopy: the effects of acetic acid and tissue homogeneity.
Gynecol Oncol. 2009;115:267-71.
PubMed Text format Related articles Abstract available

DAL BELLO B , Spinillo A, Alberizzi P, Cesari S, et al
Time trends of human papillomavirus type distribution in Italian women with cervical intraepithelial neoplasia (CIN).
Gynecol Oncol. 2009;115:262-6.
PubMed Text format Related articles Abstract available

DE LA GARZA J , Wilson SS, Behbakht K
Total pelvic exenteration with a split-thickness skin graft neovagina, continent orthotopic neobladder and rectal reanastomosis, resulting in no external ostomies and adequate sexual function.
Gynecol Oncol. 2009;115:312-3.
PubMed Text format Related articles

LIM PC
Robotic assisted total pelvic exenteration: a case report.
Gynecol Oncol. 2009;115:310-1.
PubMed Text format Related articles

RICHARDSON DL , Seamon LG, Resnick KE, Martin D, et al
Isolated groin recurrence of vulvar cancer salvaged with multimodality therapy.
Gynecol Oncol. 2009;115:306-7.
PubMed Text format Related articles

October 2009

GIEN LT , Beauchemin MC, Thomas G
Adenocarcinoma: A unique cervical cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

RECCHIA F , Di Orio F, Candeloro G, Guerriero G, et al
Maintenance immunotherapy in recurrent ovarian cancer: Long term follow-up of a phase II study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MOORE RG , Maclaughlan S, Bast RC Jr
Current state of biomarker development for clinical application in epithelial ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

ABU-RUSTUM NR , Tal MN, Delair D, Shih K, et al
Radical abdominal trachelectomy for stage IB1 cervical cancer at 15-week gestation.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

JURADO M , Alcazar JL, Martinez-Monge R
Resectability rates of previously irradiated recurrent cervical cancer (PIRCC) treated with pelvic exenteration: Is still the clinical involvement of the pelvis wall a real contraindication? A twenty-year experience.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

GORTZAK-UZAN L , Jimenez W, Nofech-Mozes S, Ismiil N, et al
Sentinel lymph node biopsy vs. pelvic lymphadenectomy in early stage cervical cancer: Is it time to change the gold standard?
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

DIETRICH CS 3RD , Greenberg VL, Desimone CP, Modesitt SC, et al
Suberoylanilide hydroxamic acid (SAHA) potentiates paclitaxel-induced apoptosis in ovarian cancer cell lines.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

PAYNE GS , Schmidt M, Morgan VA, Giles S, et al
Evaluation of magnetic resonance diffusion and spectroscopy measurements as predictive biomarkers in stage 1 cervical cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MONK BJ , Willmott LJ, Sumner DA
Anti-angiogenesis agents in metastatic or recurrent cervical cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

BENDORAITE A , Knouf EC, Garg KS, Parkin RK, et al
Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: Evidence supporting a mesothelial-to-epithelial transition.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SCOLES DR , Xu X, Wang H, Tran H, et al
Liver X receptor agonist inhibits proliferation of ovarian carcinoma cells stimulated by oxidized low density lipoprotein.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MATEI DE , Nephew KP
Epigenetic therapies for chemoresensitization of epithelial ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

D'ANGELO E , Prat J
Uterine sarcomas: A review.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MOORE DH , Tian C, Monk BJ, Long HJ, et al
Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: A Gynecologic Oncology Group Study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

COHEN Y , Shalmon B, Korach J, Barshack I, et al
AKT1 pleckstrin homology domain E17K activating mutation in endometrial carcinoma.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

FAGOTTI A , Fanfani F, Vizzielli G, Gallotta V, et al
Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery?
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

FLEMING GF , Sill MW, Darcy KM, McMeekin DS, et al
Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MATSUO K , Eno ML, Im DD, Rosenshein NB, et al
Clinical relevance of extent of extreme drug resistance in epithelial ovarian carcinoma.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

CIBULA D , Abu-Rustum NR
Pelvic lymphadenectomy in cervical cancer-surgical anatomy and proposal for a new classification system.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SABBATINI P , Spriggs D, Aghajanian C, Hensley M, et al
Consolidation strategies in ovarian cancer: Observations for future clinical trials.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

EINENKEL J , Wuttke P, Horn K
Should the extreme drug resistance assay fade into oblivion? Commentary on Karam, A.K., Chiang, J.W., Fung, E., Nossov, V. and Karlan, B.Y. Extreme drug resistance assay results do not influence survival in women with epithelial ovarian cancer. Gynecol O
Gynecol Oncol. 2009.
PubMed Text format Related articles

KOBEL M , Kalloger SE, Santos JL, Huntsman DG, et al
Tumor type and substage predict survival in stage I and II ovarian carcinoma: Insights and implications.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

LI AJ , Elmore RG, Chen IY, Karlan BY, et al
Serum low-density lipoprotein levels correlate with survival in advanced stage epithelial ovarian cancers.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

COLE LA , Muller CY
Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

CANTRELL LA , Zhou C, Mendivil A, Malloy KM, et al
Metformin is a potent inhibitor of endometrial cancer cell proliferation-implications for a novel treatment strategy.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

KARAM AK , Karlan BY
Extreme drug resistance assay does not influence survival in women with epithelial ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles

CASTELLSAGUE X , Schneider A, Kaufmann AM, Bosch FX, et al
HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

LI AJ , McAllister P, Karlan BY
Impact of androgen receptor cytosine-adenine-guanine polymorphisms on clinical outcome in BRCA mutation-associated epithelial ovarian cancers.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

KANG WD , Choi HS, Kim SM
Value of serum CA125 levels in patients with high-risk, early stage epithelial ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

UBERTI EM , Fajardo MD, Ferreira SV, Pereira MV, et al
Reproductive outcome after discharge of patients with high-risk hydatidiform mole with or without use of one bolus dose of actinomycin D, as prophylactic chemotherapy, during the uterine evacuation of molar pregnancy.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MHAWECH-FAUCEGLIA P , Herrmann FR, Wagner H, Godoy H, et al
Submission of the entire lymph node dissection for histologic examination in gynecologic-oncologic specimens. Clinical and pathologic relevance.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

HENSLEY ML , Sill MW, Scribner DR Jr, Brown J, et al
Sunitinib malate in the treatment of recurrent or persistent uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

CADRON I , Van Gorp T, Timmerman D, Amant F, et al
Application of proteomics in ovarian cancer: Which sample should be used?
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MILLER DS , Blessing JA, Drake RD, Higgins R, et al
A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologic Oncology.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

HURT JD , Richardson DL, Seamon LG, Fowler JF, et al
Sustained progression-free survival with weekly paclitaxel and bevacizumab in recurrent ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MOXLEY KM , Chengedza S, Mangiaracina D
Induction of death receptor ligand-mediated apoptosis in epithelial ovarian carcinoma: The search for sensitizing agents.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

BOURDEL N , Kondo W, Botchorishvili R, Poincloux L, et al
Assessment of sentinel nodes for gynecologic malignancies by natural orifices transluminal endoscopic surgery (NOTES): Preliminary report.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

RUSSELL AH
Forwards through the rear-view mirror.
Gynecol Oncol. 2009;115:1-3.
PubMed Text format Related articles

VAN PACHTERBEKE C , Bucella D, Rozenberg S, Manigart Y, et al
Topical treatment of CIN 2+ by cidofovir: results of a phase II, double-blind, prospective, placebo-controlled study.
Gynecol Oncol. 2009;115:69-74.
PubMed Text format Related articles Abstract available

BAE J , Seo SS, Park YS, Dong SM, et al
Natural history of persistent high-risk human papillomavirus infections in Korean women.
Gynecol Oncol. 2009;115:75-80.
PubMed Text format Related articles Abstract available

PECTASIDES D , Pectasides E, Papaxoinis G, Andreadis C, et al
Primary fallopian tube carcinoma: results of a retrospective analysis of 64 patients.
Gynecol Oncol. 2009;115:97-101.
PubMed Text format Related articles Abstract available

KURSHUMLIU F , Thorns C, Gashi-Luci L
p16INK4A in routine practice as a marker of cervical epithelial neoplasia.
Gynecol Oncol. 2009;115:127-31.
PubMed Text format Related articles Abstract available

NARDUCCI F , Lambaudie E, Houvenaeghel G, Collinet P, et al
Early experience of robotic-assisted laparoscopy for extraperitoneal para-aortic lymphadenectomy up to the left renal vein.
Gynecol Oncol. 2009;115:172-4.
PubMed Text format Related articles Abstract available

VERNOOIJ F , Witteveen PO, Verweij E, van der Graaf Y, et al
The impact of hospital type on the efficacy of chemotherapy treatment in ovarian cancer patients.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

ALVAREZ RD , Mannel R, Garcia AA, Gallion HH, et al
Fixed-dose rate gemcitabine plus carboplatin in relapsed, platinum-sensitive ovarian cancer patients: Results of a three-arm Phase I study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

AGGARWAL S , He T, Fitzhugh W, Rosenthal K, et al
Immune modulator CD70 as a potential cisplatin resistance predictive marker in ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

September 2009

YANAZUME S , Eto T, Saito T, Okadome M, et al
Diaphragmatic defect complicated with massive pleural effusion in a patient with bulky ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles

HOEKSTRA AV , Hurteau JA, Kirschner CV, Rodriguez GC, et al
The combination of monthly carboplatin and weekly paclitaxel is highly active for the treatment of recurrent ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

LIU JF , Hirsch MS, Lee H, Matulonis UA, et al
Prognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

DU XL , Jiang T, Sheng XG, Gao R, et al
Inhibition of osteopontin suppresses in vitro and in vivo angiogenesis in endometrial cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MABUCHI S , Morishige KI, Isohashi F, Yoshioka Y, et al
Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

CHEN LM , Weinberg VK, Chen C, Powell CB, et al
Perioperative outcomes comparing patient controlled epidural versus intravenous analgesia in gynecologic oncology surgery.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

JANDIAL DD , Messer K, Farshchi-Heydari S, Pu M, et al
Tumor platinum concentration following intraperitoneal administration of cisplatin versus carboplatin in an ovarian cancer model.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

CHASE DM , Rincon A, Deane M, Tewari KS, et al
Socioeconomic factors may contribute to neoadjuvant chemotherapy use in metastatic epithelial ovarian carcinoma.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SAFRA T , Menczer J, Grisaru D, Levy T, et al
Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma.
Gynecol Oncol. 2009.
PubMed Text format Related articles

JOLY F , Petit T, Pautier P, Guardiola E, et al
Weekly combination of topotecan and gemcitabine in early recurrent ovarian cancer patients: A French multicenter phase II study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

KASAMATSU T , Onda T, Sasajima Y, Kato T, et al
Prognostic significance of positive peritoneal cytology in adenocarcinoma of the uterine cervix.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

HOLLOWAY RW
Extreme drug resistance assay does not influence survival in women with epithelial ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles

IOFFE YJ , Li AJ, Walsh CS, Karlan BY, et al
Hormone receptor expression in uterine sarcomas: Prognostic and therapeutic roles.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

KHOURY-COLLADO F , Glaser GE, Zivanovic O, Sonoda Y, et al
Improving sentinel lymph node detection rates in endometrial cancer: How many cases are needed?
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

JEWELL EL , Darcy KM, Hutson A, Lee PS, et al
Association between the N-terminally truncated (DeltaN) p63alpha (DeltaNp63alpha) isoform and debulking status, VEGF expression and progression-free survival in previously untreated, advanced stage epithelial ovarian cancer: A Gynecologic Oncology Group
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MARKMAN M
"Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma" Safra T, et al (Gynecol Oncol 2009; 114:215-218).
Gynecol Oncol. 2009.
PubMed Text format Related articles

BRISTOW RE , Zahurak ML, Diaz-Montes TP, Giuntoli RL, et al
Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-term outcomes.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

WANG FQ , Barfield E, Dutta S, Pua T, et al
VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasion.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

HOLLOWAY RW , Ahmad S, Denardis SA, Peterson LB, et al
Robotic-assisted laparoscopic hysterectomy and lymphadenectomy for endometrial cancer: Analysis of surgical performance.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

WATANABE Y , Kitagawa R, Aoki D, Takeuchi S, et al
Practice pattern for postoperative management of endometrial cancer in Japan: A survey of the Japanese Gynecologic Oncology Group.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

ZIVANOVIC O , Carter J, Kauff ND, Barakat RR, et al
A review of the challenges faced in the conservative treatment of young women with endometrial carcinoma and risk of ovarian cancer, with the presentation of two cases.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

KONDALSAMY-CHENNAKESAVAN S , Bouman C, De Jong S, Sanday K, et al
Clinical audit in gynecological cancer surgery: Development of a risk scoring system to predict adverse events.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

BOIVIN M , Lane D, Piche A, Rancourt C, et al
CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MACKAY HJ , Tinker A, Winquist E, Thomas G, et al
A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

TRIMBOS B
Re: classification of radical hysterectomy.
Gynecol Oncol. 2009.
PubMed Text format Related articles

LIOTTA M , Rose PG, Escobar PF
Pulmonary hypertension in two patients treated with bevacizumab for recurrent ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles

LEITAO MM JR , Natenzon A, Abu-Rustum NR, Chi DS, et al
Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for ovarian, fallopian tube, or primary peritoneal cancers.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

BIEWENGA P , van der Velden J, Mol BW, Stalpers LJ, et al
Validation of existing prognostic models in patients with early-stage cervical cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

DUSKA LR
Can we improve the detection of glandular cervical lesions: the role and limitations of the Pap smear diagnosis atypical glandular cells (AGC).
Gynecol Oncol. 2009;114:381-2.
PubMed Text format Related articles

MAURO JE , Bertolino MV, Basilio F, Nassif JC, et al
A series of 21 cases using cryosurgery, a novel technique for managing advanced or extended vulvar cancer in medically debilitated patients.
Gynecol Oncol. 2009;114:542-3.
PubMed Text format Related articles

ZHAO C , Florea A, Onisko A, Austin RM, et al
Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: results from a large academic womens hospital laboratory employing sensitive screening methods.
Gynecol Oncol. 2009;114:383-9.
PubMed Text format Related articles Abstract available

RAJENDRAN S , Hodgnett P, O'Hanlon D, Curtain A, et al
Antegrade deligation of iatrogenic distal ureteric obstruction utilising a high pressure balloon dilatation technique.
Gynecol Oncol. 2009;114:538-9.
PubMed Text format Related articles Abstract available

August 2009

FIORICA JV , Blessing JA, Puneky LV, Secord AA, et al
A Phase II evaluation of weekly topotecan as a single agent second line therapy in persistent or recurrent carcinoma of the cervix: A Gynecologic Oncology Group study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

FOSTER T , Brown TM, Chang J, Menssen HD, et al
A review of the current evidence for maintenance therapy in ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

ESCOBAR PF , Fader AN
E-NOTES: Promising minimal surgical approach for gynecologic disease.
Gynecol Oncol. 2009.
PubMed Text format Related articles

FADER AN , Starks D, Gehrig PA, Secord AA, et al
An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC).
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

AGHAJANIAN C , Blessing JA, Darcy KM, Reid G, et al
A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

TONG SY , Lee JM, Song ES, Lee KB, et al
Functional polymorphism in manganese superoxide dismutase and antioxidant status: Their interactions on the risk of cervical intraepithelial neoplasia and cervical cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

BEAUCHAMP MC , Knafo A, Yasmeen A, Carboni JM, et al
BMS-536924 sensitizes human epithelial ovarian cancer cells to the PARP inhibitor, 3-aminobenzamide.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

LIM MC , Park SY, Seo SS
E-NOTES: Promising minimal surgical approach for gynecologic disease.
Gynecol Oncol. 2009.
PubMed Text format Related articles

BRISTOW RE , Chi DS
Response to "Indefinitely prolonged survival after relapse in advanced ovarian cancer: The other end of the telescope"
Gynecol Oncol. 2009.
PubMed Text format Related articles

MARKMAN M
Comparative effectiveness research: A proposal for funding in ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles

SECORD AA , Neubauer NL
In response to "The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinoma"
Gynecol Oncol. 2009.
PubMed Text format Related articles

QUERLEU D , Morrow CP
Classification of radical hysterectomy.
Gynecol Oncol. 2009.
PubMed Text format Related articles

KUMPULAINEN S , Sankila R, Leminen A, Kuoppala T, et al
The effect of hospital operative volume, residual tumor and first-line chemotherapy on survival of ovarian cancer - A prospective nation-wide study in Finland.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SIGNORELLI M , Guerra L, Buda A, Picchio M, et al
Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: Detection of pelvic nodal metastases.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

TCHABO NE , McCloskey S, Mashtare TL, Andrews C, et al
Treatment of early-stage uterine papillary serous carcinoma at Roswell Park Cancer Institute, 1992-2006.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

GIEN LT , Barbera L, Kupets R, Saskin R, et al
Utilization of preoperative imaging in uterine cancer patients.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SCHMID S , Hsu IC, Hu JM, Sherman AE, et al
Adjuvant radiation therapy in stage III node-positive uterine cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SIDEBOTHAM EL , Delair D, Comerci JT, Kayton ML, et al
Pediatric radical abdominal trachelectomy for solitary fibrous tumor of the uterine cervix.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

ABU-RUSTUM NR , Gomez JD, Alektiar KM, Soslow RA, et al
The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

INABA T , Ino K, Kajiyama H, Yamamoto E, et al
Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

ZIVANOVIC O , Sima CS, Iasonos A, Bell-McGuinn KM, et al
Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

BANSAL M , Austin RM, Zhao C
High-risk HPV DNA detected in less than 2% of over 25,000 cytology negative imaged liquid-based Pap test samples from women 30 and older.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

BOYCE EA , Costaggini I, Vitonis A, Feltmate C, et al
The epidemiology of ovarian granulosa cell tumors: A case-control study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

PRISTAUZ G , Bader AA, Regitnig P, Haas J, et al
How accurate is frozen section histology of pelvic lymph nodes in patients with endometrial cancer?
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

TRIMBLE EL
Cervical cancer state-of-the-clinical-science meeting on pretreatment evaluation and prognostic factors, September 27-28, 2007: proceedings and recommendations.
Gynecol Oncol. 2009;114:145-50.
PubMed Text format Related articles Abstract available

RAMIREZ PT
Single-port laparoscopic surgery: is a single incision the next frontier in minimally invasive gynecologic surgery?
Gynecol Oncol. 2009;114:143-4.
PubMed Text format Related articles

KLERKX WM , Heintz AP, Mali WP, de Kort GA, et al
Lymph node detection by MRI before and after a systematic pelvic lymphadenectomy.
Gynecol Oncol. 2009;114:315-8.
PubMed Text format Related articles Abstract available

FONS G , Groenen SM, Oonk MH, Ansink AC, et al
Adjuvant radiotherapy in patients with vulvar cancer and one intra capsular lymph node metastasis is not beneficial.
Gynecol Oncol. 2009;114:343-5.
PubMed Text format Related articles Abstract available

ZUBEL A , Flechtenmacher C, Edler L, Alonso A, et al
Expression of ADAM9 in CIN3 lesions and squamous cell carcinomas of the cervix.
Gynecol Oncol. 2009;114:332-6.
PubMed Text format Related articles Abstract available

CASTLE PE , Fetterman B, Akhtar I, Husain M, et al
Age-appropriate use of human papillomavirus vaccines in the U.S.
Gynecol Oncol. 2009;114:365-9.
PubMed Text format Related articles Abstract available

KRAEMER B , Guengoer E, Solomayer EF, Wallwiener D, et al
Stage I carcinoma of the Bartholin's gland managed with the detection of inguinal and pelvic sentinel lymph node.
Gynecol Oncol. 2009;114:373-4.
PubMed Text format Related articles Abstract available

SONG YJ , Lim MC, Kang S, Seo SS, et al
Total colectomy as part of primary cytoreductive surgery in advanced Mullerian cancer.
Gynecol Oncol. 2009;114:183-7.
PubMed Text format Related articles Abstract available

LIANG Z , Chen G, Xu H, Chen Y, et al
A model program for radical hysterectomy for cervical cancer: Asia Pacific perspective.
Gynecol Oncol. 2009;114.
PubMed Text format Related articles Abstract available

ZIVANOVIC O , Aldini A, Carlson JW, Chi DS, et al
Advanced cytoreductive surgery: American perspective.
Gynecol Oncol. 2009;114.
PubMed Text format Related articles Abstract available

CRANDON AJ , Obermair A
Advanced cytoreductive surgery: Asia Pacific perspective.
Gynecol Oncol. 2009;114.
PubMed Text format Related articles Abstract available

VERLEYE L , Ottevanger PB, Vergote I
Surgical program building in advanced ovarian cancer: European perspective.
Gynecol Oncol. 2009;114.
PubMed Text format Related articles Abstract available

BRISTOW RE
Advanced cytoreductive surgery in gynecologic oncology.
Gynecol Oncol. 2009;114.
PubMed Text format Related articles

CIBULA D , Kesic V
Surgical education and training in gynecologic oncology I: European perspective.
Gynecol Oncol. 2009;114.
PubMed Text format Related articles Abstract available

HOFFMAN MS , Bodurka DC
Surgical education and training program development for gynecologic oncology: American perspective.
Gynecol Oncol. 2009;114.
PubMed Text format Related articles Abstract available

GOFF BA
Surgical education for gynecologic oncologists.
Gynecol Oncol. 2009;114.
PubMed Text format Related articles

LEBLANC E , Narducci F, Ferron G, Querleu D, et al
Indications and teaching of fertility preservation in the surgical management of gynecologic malignancies: European perspective.
Gynecol Oncol. 2009;114.
PubMed Text format Related articles Abstract available

MENDIVIL A , Holloway RW, Boggess JF
Emergence of robotic assisted surgery in gynecologic oncology: American perspective.
Gynecol Oncol. 2009;114.
PubMed Text format Related articles Abstract available

MAGRINA JF
Minimally invasive surgery in gynecologic oncology.
Gynecol Oncol. 2009;114.
PubMed Text format Related articles

July 2009

TAYLOR DD , Gercel-Taylor C, Parker LP
Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

KOBAYASHI E , Iwamiya T, Isobe M, Miyake T, et al
A novel technique for the management of the vesicouterine ligament during radical hysterectomy.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

HALL JB
Letter to the Editor regarding "A case matched analysis of robotic radical hysterectomy with lymphadenectomy compared with laparoscopy and laparotomy"
Gynecol Oncol. 2009.
PubMed Text format Related articles

NISHIO H , Fujii T, Kameyama K, Susumu N, et al
Abdominal radical trachelectomy as a fertility-sparing procedure in women with early-stage cervical cancer in a series of 61 women.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

CIBULA D , Kuzel D, Slama J, Fischerova D, et al
Sentinel node (SLN) biopsy in the management of locally advanced cervical cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

DJORDJEVIC B , Gien LT, Covens A, Malpica A, et al
Polypoid or non-polypoid? A novel dichotomous approach to uterine carcinosarcoma.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MAGGIONI A , Minig L, Zanagnolo V, Peiretti M, et al
Robotic approach for cervical cancer: Comparison with laparotomy A case control study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

LEE TS , Kim JW, Kim TJ, Cho CH, et al
Ovarian preservation during the surgical treatment of early stage endometrial cancer: A nation-wide study conducted by the Korean Gynecologic Oncology Group.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MARKMAN M
Response to: "Establishing evidence for change in ovarian cancer surgery - Proposing clinical trials of cytoreductive surgery and hyperthermic chemotherapy (HIPEC) in ovarian cancer peritoneal carcinomastis (Chua TC, et al.)"
Gynecol Oncol. 2009.
PubMed Text format Related articles

KLOPP AH , Jhingran A, Ramondetta L, Lu K, et al
Node-positive adenocarcinoma of the endometrium: Outcome and patterns of recurrence with and without external beam irradiation.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

WETHINGTON SL , Barrena Medel NI, Wright JD, Herzog TJ, et al
Prognostic significance and treatment implications of positive peritoneal cytology in endometrial adenocarcinoma: Unraveling a mystery.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

POWLESS CA , Bakkum-Gamez JN, Aletti GD, Cliby WA, et al
Random peritoneal biopsies have limited value in staging of apparent early stage epithelial ovarian cancer after thorough exploration.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

NOSKOVA V , Ahmadi S, Asander E, Casslen B, et al
Ovarian cancer cells stimulate uPA gene expression in fibroblastic stromal cells via multiple paracrine and autocrine mechanisms.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

VILLAVICENCIO A , Goyeneche A, Telleria C, Bacallao K, et al
Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

FOLKINS AK , Saleemuddin A, Garrett LA, Garber JE, et al
Epidemiologic correlates of ovarian cortical inclusion cysts (CICs) support a dual precursor pathway to pelvic epithelial cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

CHI DS , Bristow RE
In response to: Establishing evidence for change in ovarian cancer surgery - Proposing clinical trials of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer peritoneal carcinomatosis.
Gynecol Oncol. 2009.
PubMed Text format Related articles

HSU WC , Chung NN, Chen YC, Ting LL, et al
Comparison of surgery or radiotherapy on complications and quality of life in patients with the stage IB and IIA uterine cervical cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

LIM MC , Park SY
Surgical results of hepatic metastatectomy in patients with primary epithelial ovarian carcinoma.
Gynecol Oncol. 2009.
PubMed Text format Related articles

CHUA TC , Liauw W, Robertson G, Morris DL, et al
Establishing evidence for change in ovarian cancer surgery - Proposing clinical trials of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer peritoneal carcinomatosis.
Gynecol Oncol. 2009.
PubMed Text format Related articles

LEE YY , Choi CH, Kim CJ, Kang H, et al
The prognostic significance of the SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: Preliminary results.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

KRIVAK TC , Tian C, Rose GS, Armstrong DK, et al
A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemotherapy: An analysis of patients enrolled in GOG 172.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

BORUTA DM 2ND , Gehrig PA, Fader AN, Olawaiye AB, et al
Management of women with uterine papillary serous cancer: A Society of Gynecologic Oncology (SGO) review.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

PERSSON J , Reynisson P, Bossmar T
Response to letter to by Dr Sert concerning the article "Robot assisted laparoscopic radical hysterectomy and pelvic lymphadenectomy with short and long term morbidity data"
Gynecol Oncol. 2009.
PubMed Text format Related articles

MATEI D , Schilder J, Sutton G, Perkins S, et al
Activity of 2 methoxyestradiol (Panzem((R)) NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: A Hoosier Oncology Group trial.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

NUGENT EK , Zighelboim I, Case AS, Gao F, et al
The value of perioperative imaging in patients with uterine sarcomas.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

VICUS D , Rosen B, Lubinski J, Domchek S, et al
Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriers.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

THOMAS G
Letter to the Editor Re. Paper: "The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinoma"
Gynecol Oncol. 2009.
PubMed Text format Related articles

NI BHRIAIN H , Trovik J, Wik E, Stefansson IM, et al
Plasma calprotectin concentrations in women with endometrial carcinoma.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

YEN MS , Twu NF, Lai CR, Horng HC, et al
Importance of delivered cycles and nomogram for intraperitoneal chemotherapy in ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

BERCHUCK A
Microarray analysis of gene expression in gynecologic cancers--still only the beginning.
Gynecol Oncol. 2009;114:1-2.
PubMed Text format Related articles

MAGGIONI A , Roviglione G, Landoni F, Zanagnolo V, et al
Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan.
Gynecol Oncol. 2009;114:64-8.
PubMed Text format Related articles Abstract available

ALETTI GD , Powless C, Bakkum-Gamez J, Wilson TO, et al
Pattern of retroperitoneal dissemination of primary peritoneum cancer: basis for rational use of lymphadenectomy.
Gynecol Oncol. 2009;114:32-6.
PubMed Text format Related articles Abstract available

CHANG HL , Pahlavan N, Halpern EF, MacLaughlin DT, et al
Serum Mullerian Inhibiting Substance/anti-Mullerian hormone levels in patients with adult granulosa cell tumors directly correlate with aggregate tumor mass as determined by pathology or radiology.
Gynecol Oncol. 2009;114:57-60.
PubMed Text format Related articles Abstract available

GARDNER FJ , Konje JC, Bell SC, Abrams KR, et al
Prevention of tamoxifen induced endometrial polyps using a levonorgestrel releasing intrauterine system Long-term follow-up of a randomised control trial.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SCHLOSSHAUER PW , Li W, Lin KT, Chan JL, et al
Rapamycin by itself and additively in combination with carboplatin inhibits the growth of ovarian cancer cells.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

June 2009

NAVARRIA I , Usel M, Rapiti E, Neyroud-Caspar I, et al
Young patients with endometrial cancer: How many could be eligible for fertility-sparing treatment?
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SECORD AA , Havrilesky LJ, O'Malley DM, Bae-Jump V, et al
A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

ARIAS-PULIDO H , Smith HO, Joste NE, Bocklage T, et al
Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

BRYANT CS , Kumar S, Shah JP, Mahdi H, et al
Racial disparities in survival among patients with germ cell tumors of the ovary-United States.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

AYE C , Jefferis H, Chung DY, Manek S, et al
A case of multi-modal managed vulval aggressive angiomyxoma diagnosed before conception and monitored during pregnancy.
Gynecol Oncol. 2009.
PubMed Text format Related articles

IVY JJ , Geller M, Pierson SM, Jonson AL, et al
Outcomes associated with different intraperitoneal chemotherapy delivery systems in advanced ovarian carcinoma: A single institution's experience.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

ELIT L , Fyles AW, Devries MC, Oliver TK, et al
Follow-up for women after treatment for cervical cancer: A systematic review.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

VEERAPANENI P , Kirma N, Nair HB, Hammes LS, et al
Elevated aromatase expression correlates with cervical carcinoma progression.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SILVER DF , Zgheib NB
Extended left colon resections as part of complete cytoreduction for ovarian cancer: Tips and considerations.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

COLOMBO PE , Bertrand MM, Gutowski M, Mourregot A, et al
Total laparoscopic radical hysterectomy for locally advanced cervical carcinoma (stages IIB, IIA and bulky stages IB) after concurrent chemoradiation therapy: Surgical morbidity and oncological results.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SFAKIANOS GP , Numnum TM, Halverson CB, Panjeti D, et al
The risk of gastrointestinal perforation and/or fistula in patients with recurrent ovarian cancer receiving bevacizumab compared to standard chemotherapy: A retrospective cohort study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

PANDEY S , Mittal RD, Srivastava M, Srivastava K, et al
Impact of Toll-like receptors [TLR] 2 (-196 to -174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

FULHAM MJ , Carter J, Hicks R
The impact of PET-CT in suspected recurrent ovarian cancer: A prospective multi-centre study as part of the Australian PET Data Collection Project: Response to a letter from Dr. Maure Markman.
Gynecol Oncol. 2009.
PubMed Text format Related articles

RADES D , Fischer D, Veninga T, Stalpers LJ, et al
Prognostic factors for survival and intracerebral control after irradiation for brain metastases from gynecological cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SERT MB
Robot assisted laparoscopic radical hysterectomy and pelvic lymphadenectomy with short and long term morbidity.
Gynecol Oncol. 2009.
PubMed Text format Related articles

OH JH , Kim JH, Ahn HJ, Yoon JH, et al
Syndecan-1 enhances the endometrial cancer invasion by modulating matrix metalloproteinase-9 expression through nuclear factor kappaB.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

TAO X , Sood AK, Deavers MT, Schmeler KM, et al
Anti-angiogenesis therapy with bevacizumab for patients with ovarian granulosa cell tumors.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

DARCY KM , Brady WE, Blancato JK, Dickson RB, et al
Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: A Gynecologic Oncology Group study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SEAMON LG , Downey GO, Harrison CR, Doss B, et al
Neoadjuvant chemotherapy followed by post-partum chemoradiotherapy and chemoconsolidation for stage IIIB glassy cell cervical carcinoma during pregnancy.
Gynecol Oncol. 2009.
PubMed Text format Related articles

BACKES FJ , Leon ME, Ivanov I, Suarez A, et al
Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

POWER P , Stuart G, Oza A, Provencher D, et al
Efficacy of pegylated liposomal doxorubicin (PLD) plus carboplatin in ovarian cancer patients who recur within six to twelve months: A phase II study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

KAPNICK J , Helgason H
Indefinitely prolonged survival after relapse in advanced ovarian cancer: The other end of the telescope.
Gynecol Oncol. 2009.
PubMed Text format Related articles

SMITH HO , Arias-Pulido H, Kuo DY, Howard T, et al
GPR30 predicts poor survival for ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

JIMENEZ W , Paszat L, Kupets R, Wilton A, et al
Presumed previous human papillomavirus (HPV) related gynecological cancer in women diagnosed with anal cancer in the province of Ontario.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

HU X , Macdonald DM, Huettner PC, Feng Z, et al
A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

QUINT KD , de Koning MN, Geraets DT, Quint WG, et al
Comprehensive analysis of Human Papillomavirus and Chlamydia trachomatis in in-situ and invasive cervical adenocarcinoma.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

STITT IA , Stany MP, Moser RP 3rd, Rose GS, et al
Incidental gynecological findings on computed tomographic colonography: Prevalence and outcomes.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

WENZEL L
Patient-reported outcomes in sentinel lymph node procedure versus inguinofemoral lymphadenectomy: what is the next step?
Gynecol Oncol. 2009;113:299-300.
PubMed Text format Related articles

EIJSINK JJ , de Bock GH, Kuiper JL, Reesink-Peters N, et al
Routine follow-up intervals in patients with high-grade squamous intraepithelial lesions (HSIL) and free excision margins can safely be increased in the first two years after Large Loop Excision of the Transformation Zone (LLETZ).
Gynecol Oncol. 2009;113:348-51.
PubMed Text format Related articles Abstract available

OONK MH , van Os MA, de Bock GH, de Hullu JA, et al
A comparison of quality of life between vulvar cancer patients after sentinel lymph node procedure only and inguinofemoral lymphadenectomy.
Gynecol Oncol. 2009;113:301-5.
PubMed Text format Related articles Abstract available

ZHANG W , Peng Z, Xu L
Extragastrointestinal stromal tumor arising in the rectovaginal septum: report of an unusual case with literature review.
Gynecol Oncol. 2009;113:399-401.
PubMed Text format Related articles Abstract available

FOLKINS AK , Jarboe EA, Roh MH, Crum CP, et al
Precursors to pelvic serous carcinoma and their clinical implications.
Gynecol Oncol. 2009;113:391-6.
PubMed Text format Related articles Abstract available

MOORE DH
Chemotherapy and radiation therapy in the treatment of squamous cell carcinoma of the vulva: Are two therapies better than one?
Gynecol Oncol. 2009;113:379-83.
PubMed Text format Related articles Abstract available

May 2009

BRISTOW RE , Peiretti M, Gerardi M, Zanagnolo V, et al
Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: Operative technique and clinical outcome.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

ZHOU X , Han S, Wang S, Chen X, et al
Polymorphisms in HPV E6/E7 protein interacted genes and risk of cervical cancer in Chinese women: A case-control analysis.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MARKMAN M
The impact of PET-CT in suspected recurrent ovarian cancer: A prospective multi-centre study as part of the Australian PET Data Collection Project.
Gynecol Oncol. 2009.
PubMed Text format Related articles

KURDOGLU M , Bayram I, Kolusari A, Erten R, et al
Expression of laminin receptor 1 in gestational trophoblastic diseases and normal placenta and its relationship with the development of postmolar tumors.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

WU TI , Lee CL, Wu MY, Hsueh S, et al
Prognostic factors predicting recurrence in borderline ovarian tumors.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

HARIRI LP , Bonnema GT, Schmidt K, Winkler AM, et al
Laparoscopic optical coherence tomography imaging of human ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MIRABEAU-BEALE KL , Kornblith AB, Penson RT, Lee H, et al
Comparison of the quality of life of early and advanced stage ovarian cancer survivors.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

FADER AN , Escobar PF
Laparoendoscopic single-site surgery (LESS) in gynecologic oncology: Technique and initial report.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

RAHKOLA P , Mikkola TS, Ylikorkala O, Vaisanen-Tommiska M, et al
Association between high risk papillomavirus DNA and nitric oxide release in the human uterine cervix.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MORGAN J , Hoekstra AV, Chapman-Davis E, Hardt JL, et al
Synuclein-gamma (SNCG) may be a novel prognostic biomarker in uterine papillary serous carcinoma.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MCMEEKIN DS , Lisyanskaya A, Crispens M, Oza AM, et al
Single-agent trabectedin as second-line therapy of persistent or recurrent endometrial cancer: Results of a multicenter phase II study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SMITH HO , Moon J, Wilczynski SP, Tiersten AD, et al
Southwest Oncology Group Trial S9912: Intraperitoneal cisplatin and paclitaxel plus intravenous paclitaxel and pegylated liposomal doxorubicin as primary chemotherapy of small-volume residual stage III ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

LURIE G , Thompson PJ, McDuffie KE, Carney ME, et al
Prediagnostic symptoms of ovarian carcinoma: A case-control study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

LEVENBACK CF , van der Zee AG, Rob L, Plante M, et al
Sentinel lymph node biopsy in patients with gynecologic cancers Expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

FOTIOU S , Aliki T, Petros Z, Ioanna S, et al
Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

WANG L , Madigan MC, Chen H, Liu F, et al
Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

ROCCONI RP , Matthews KS, Kemper MK, Hoskins KE, et al
The timing of normalization of CA-125 levels during primary chemotherapy is predictive of survival in patients with epithelial ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MARKMAN M , Liu PY, Moon J, Monk BJ, et al
Impact on survival of 12 versus 3 monthly cycles of paclitaxel (175 mg/m(2)) administered to patients with advanced ovarian cancer who attained a complete response to primary platinum-paclitaxel: Follow-up of a Southwest Oncology Group and Gynecologic On
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

ALTGASSEN C , Muller N, Hornemann A, Kavallaris A, et al
Immunohistochemical workup of sentinel nodes in endometrial cancer improves diagnostic accuracy.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

LANDRUM LM , McMeekin DS
Response to "Residual tumor after neoadjuvant chemotherapy and interval debulking for advanced endometrial cancer"
Gynecol Oncol. 2009.
PubMed Text format Related articles

HOEKSTRA AV , Morgan JM, Lurain JR, Buttin BM, et al
Robotic surgery in gynecologic oncology: Impact on fellowship training.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

TANYI JL , Smith JA, Ramos L, Parker CL, et al
Predisposing risk factors for palmar-plantar erythrodysesthesia when using liposomal doxorubicin to treat recurrent ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

BRICOU A , Barranger E, Uzan S, Darai E, et al
Anaphylactic shock during the sentinel lymph node procedure for cervical cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

YU KJ , Rader JS, Borecki I, Zhang Z, et al
CD83 polymorphisms and cervical cancer risk.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

HAVRILESKY LJ , Secord AA, O'Malley DM, Broadwater G, et al
Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

KANG H , Kim TJ, Lee YY, Choi CH, et al
Topotecan combined with carboplatin in recurrent epithelial ovarian cancer: Results of a single-institutional phase II study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SAFRA T , Menczer J, Bernstein RM, Shpigel S, et al
Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

KIZER NT , Zighelboim I, Case AS, Dewdney SB, et al
The role of PET/CT in the management of patients with cervical cancer: Practice patterns of the members of the Society of Gynecologic Oncologists.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

EITAN R , Kushnir M, Lithwick-Yanai G, David MB, et al
Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

FARGHALY SA
Observation on the surgical aspect of resection of noncolorectal nonneuroendocrine hepatic parenchymal metastasis in patients with primary epithelial ovarian carcinoma.
Gynecol Oncol. 2009.
PubMed Text format Related articles

MEIER W , du Bois A, Reuss A, Kuhn W, et al
Topotecan versus treosulfan, an alkylating agent, in patients with epithelial ovarian cancer and relapse within 12 months following 1st-line platinum/paclitaxel chemotherapy. A prospectively randomized phase III trial by the Arbeitsgemeinschaft Gynaekolo
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SEAMON LG , Fowler JM, Richardson DL, Carlson MJ, et al
A detailed analysis of the learning curve: Robotic hysterectomy and pelvic-aortic lymphadenectomy for endometrial cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

HOEKSTRA AV , Kim RJ, Small W Jr, Rademaker AW, et al
FIGO stage IIIC endometrial carcinoma: Prognostic factors and outcomes.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

UBERTI EM , Fajardo MD, da Cunha AG, Rosa MW, et al
Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: A simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SATO T , Ota T, Watanabe M, Imada K, et al
Identification of an active site of EMMPRIN for the augmentation of matrix metalloproteinase-1 and -3 expression in a co-culture of human uterine cervical carcinoma cells and fibroblasts.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

LOWE KA , Andersen MR, Urban N, Paley P, et al
The temporal stability of the Symptom Index among women at high-risk for ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

PEEDICAYIL A , Vierkant RA, Shridhar V, Schildkraut JM, et al
Polymorphisms in TCEAL7 and risk of epithelial ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

GOODFELLOW PJ
Clinicopathologic significance of DNA mismatch repair defects in endometrial cancer: the devil is in the details.
Gynecol Oncol. 2009;113:151-2.
PubMed Text format Related articles

FRANCHELLI S , Leone MS, Bruzzone M, Muggianu M, et al
The gluteal fold fascio-cutaneous flap for reconstruction after radical excision of primary vulvar cancers.
Gynecol Oncol. 2009;113:245-8.
PubMed Text format Related articles Abstract available

TAN W , Stehman FB, Carter RL
Mortality rates due to gynecologic cancers in New York state by demographic factors and proximity to a Gynecologic Oncology Group member treatment center: 1979-2001.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

DE JONG RA , Leffers N, Boezen HM, Ten Hoor KA, et al
Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

April 2009

CHIEN J , Fan JB, Bell DA, April C, et al
Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MASSAD LS , Einstein M, Myers E, Wheeler CM, et al
The impact of human papillomavirus vaccination on cervical cancer prevention efforts.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

NAUMANN RW , Sukumvanich P, Edwards RP
Practice patterns of intraperitoneal chemotherapy in women with ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

RICHTER CE , Qian B, Martel M, Yu H, et al
Ovarian preservation and staging in reproductive-age endometrial cancer patients.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

BROOKS RA , Wright JD, Powell MA, Rader JS, et al
Long-term assessment of bladder and bowel dysfunction after radical hysterectomy.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

NOYES N , Abu-Rustum NR, Ramirez PT, Plante M, et al
Options in the management of fertility-related issues after radical trachelectomy in patients with early cervical cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles

BOSE CK
Is randomized trial of neoadjuvant chemotherapy of ovarian cancer necessary?
Gynecol Oncol. 2009.
PubMed Text format Related articles

O'MEARA AC , Giger OT, Kurrer M, Schaer G, et al
Case report: Recurrence of a uterine tumor resembling ovarian sex-cord tumor.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

FADER AN , Arriba LN, Frasure HE, von Gruenigen VE, et al
Endometrial cancer and obesity: Epidemiology, biomarkers, prevention and survivorship.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

LUPE K , D'Souza DP, Kwon JS, Radwan JS, et al
Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

TSAI-TURTON M , Santillan A, Lu D, Bristow RE, et al
p53 autoantibodies, cytokine levels and ovarian carcinogenesis.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

AMANT F , Despierre E, Vandenput I
Residual tumor after neoadjuvant chemotherapy and interval debulking surgery for advanced endometrial cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles

KASAMATSU T , Onda T, Sawada M, Kato T, et al
Radical hysterectomy for FIGO stage IIB cervical cancer: Clinicopathological characteristics and prognostic evaluation.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MARKMAN M
In response to: "Towards randomized trials of peritonectomy and hyperthermic intraperitoneal chemotherapy for ovarian cancer peritoneal carcinomatosis"
Gynecol Oncol. 2009.
PubMed Text format Related articles

LAN C , Li Y, Liu J
Intraperitoneal access via direct puncture is an alternative way to deliver intraperitoneal chemotherapy in ovarian, fallopian tube and primary peritoneal cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SEPPO A , Jalali GR, Babkowski R, Symiakaki H, et al
Gain of 3q26: A genetic marker in low-grade squamous intraepithelial lesions (LSIL) of the uterine cervix.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

GHAMANDE SA , Silverman M, Gold M
A Phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles

CHI DS , Eisenhauer EL, Zivanovic O, Sonoda Y, et al
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

FERGUSON SE , Malhotra T, Seshan VE, Levine DA, et al
A prospective randomized trial comparing patient-controlled epidural analgesia to patient-controlled intravenous analgesia on postoperative pain control and recovery after major open gynecologic cancer surgery.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

RESNICK KE , Hampel H, Fishel R, Cohn DE, et al
Current and emerging trends in Lynch syndrome identification in women with endometrial cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

CAI KQ , Wu H, Klein-Szanto AJ, Xu XX, et al
Acquisition of a second mutation of the Tp53 alleles immediately precedes epithelial morphological transformation in ovarian tumorigenicity.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

PALOMBA S , Falbo A, Russo T, Zullo F, et al
Updating of a recent meta-analysis of randomized controlled trials to assess the safety and the efficacy of the laparoscopic surgery for treating early stage endometrial cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles

CHUA TC , Liauw W, Robertson G, Chia WK, et al
Towards randomized trials of cytoreductive surgery using peritonectomy and hyperthermic intraperitoneal chemotherapy for ovarian cancer peritoneal carcinomatosis.
Gynecol Oncol. 2009.
PubMed Text format Related articles

GERSHENSON DM , Sun CC, Bodurka D, Coleman RL, et al
Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

FENNIMORE IA , Simon NL, Bills G, Dryfhout VL, et al
Extension of ovarian tissue into the infundibulopelvic ligament beyond visual margins.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

LI J , Jia H, Xie L, Wang X, et al
Correlation of inhibitor of differentiation 1 expression to tumor progression, poor differentiation and aggressive behaviors in cervical carcinoma.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SCHWARTZ J , Toste B, Dizon DS
Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA)>2 m(2).
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

ALAM SM , Fujimoto J, Jahan I, Sato E, et al
Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

FENG F , Xiang Y, Li L, Wan X, et al
Clinical parameters predicting therapeutic response to surgical management in patients with chemotherapy-resistant gestational trophoblastic neoplasia.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

ESTAPE R , Lambrou N, Diaz R, Estape E, et al
A case matched analysis of robotic radical hysterectomy with lymphadenectomy compared with laparoscopy and laparotomy.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

TIRO AV , Talukdar R, Lewis MG
A unique case of serous psammocarcinoma of the ovary presenting with pleural effusion and manifesting psammoma body implants in the pleural cavity and pericardium.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

FAGOTTI A , Paris I, Grimolizzi F, Fanfani F, et al
Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: A pilot study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

OREZZOLI JP , Sioletic S, Olawaiye A, Oliva E, et al
Stage II endometrioid adenocarcinoma of the endometrium: Clinical implications of cervical stromal invasion.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

Hereditary breast and ovarian cancer syndrome.
Gynecol Oncol. 2009;113:6-11.
PubMed Text format Related articles

MONK BJ , Ali S, Gaffney DK
When is being in a hurry going too fast? Lessons learned from clinical trials in cervical cancer.
Gynecol Oncol. 2009;113:1-3.
PubMed Text format Related articles

SEAMON LG , Holt CN, Suarez A, Richardson DL, et al
Paratubal borderline serous tumors.
Gynecol Oncol. 2009;113:83-5.
PubMed Text format Related articles Abstract available

SPINILLO A , Dal Bello B, Gardella B, Roccio M, et al
Multiple human papillomavirus infection and high grade cervical intraepithelial neoplasia among women with cytological diagnosis of atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions.
Gynecol Oncol. 2009;113:115-9.
PubMed Text format Related articles Abstract available

ISMIIL N , Ghorab Z, Covens A, Nofech-Mozes S, et al
Intraoperative margin assessment of the radical trachelectomy specimen.
Gynecol Oncol. 2009;113:42-6.
PubMed Text format Related articles Abstract available

MATOVINA M , Sabol I, Grubisic G, Gasperov NM, et al
Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions.
Gynecol Oncol. 2009;113:120-7.
PubMed Text format Related articles Abstract available

MAGRINA JF , Kho R, Montero RP, Magtibay PM, et al
Robotic extraperitoneal aortic lymphadenectomy: Development of a technique.
Gynecol Oncol. 2009;113:32-5.
PubMed Text format Related articles Abstract available

TRIMBOS JB
TNM-like classification of radical hysterectomy.
Gynecol Oncol. 2009.
PubMed Text format Related articles

GERESTEIN CG , Damhuis RA, Burger CW, Kooi GS, et al
Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: A systematic review.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

March 2009

GUNTUPALLI SR , Ramirez PT, Anderson ML, Milam MR, et al
Uterine smooth muscle tumor of uncertain malignant potential: A retrospective analysis.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

ANSENBERGER K , Zhuge Y, Lagman JA, Richards C, et al
E-cadherin expression in ovarian cancer in the laying hen, Gallus domesticus, compared to human ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

DANN JM , Sykes PH, Mason DR, Evans JJ, et al
Regulation of Vascular Endothelial Growth Factor in endometrial tumour cells by resveratrol and EGCG.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

GUPTA D , Owers RL, Kim M, Kuo DY, et al
A phase II study of weekly topotecan and docetaxel in heavily treated patients with recurrent uterine and ovarian cancers.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

KARAM AK , Chiang JW, Fung E, Nossov V, et al
Extreme drug resistance assay results do not influence survival in women with epithelial ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

ARABI H , Guan H, Kumar S, Cote M, et al
Impact of microsatellite instability (MSI) on survival in high grade endometrial carcinoma.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SHIMADA M , Kigawa J, Ohishi Y, Yasuda M, et al
Clinicopathological characteristics of mucinous adenocarcinoma of the ovary.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

FARLEY J , Fuchiuji S, Darcy KM, Tian C, et al
Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: A Gynecologic Oncology Group study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

HAYES MP , Douglas W, Ellenson LH
Molecular alterations of EGFR and PIK3CA in uterine serous carcinoma.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

EL-HELW LM , Coleman RE, Everard JE, Tidy JA, et al
Impact of the revised FIGO/WHO system on the management of patients with gestational trophoblastic neoplasia.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

TINELLI R , Cicinelli E, Tinelli A, Malzoni M, et al
Total laparoscopic hysterectomy versus abdominal hysterectomy with lymphadenectomy for early-stage endometrial cancer: A prospective randomized study.
Gynecol Oncol. 2009.
PubMed Text format Related articles

MABUCHI S , Morishige K, Fujita M, Tsutsui T, et al
The activity of carboplatin and paclitaxel for recurrent cervical cancer after definitive radiotherapy.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SANTOSO JT , Azadi A, Wan J, Handorf C, et al
Lymph node counts in uterine cancer: A randomized double blind trial.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

PLUTA M , Rob L, Charvat M, Chmel R, et al
Less radical surgery than radical hysterectomy in early stage cervical cancer - A pilot study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SCHMELER KM , Vadhan-Raj S, Ramirez PT, Apte SM, et al
A phase II study of GM-CSF and rIFN-gamma1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

BEGUM FD , Hogdall E, Kjaer SK, Blaakaer J, et al
Preoperative serum tetranectin, CA125 and menopausal status used as single markers in screening and in a risk assessment index (RAI) in discriminating between benign and malignant ovarian tumors.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

WALKER JL
Intraperitoneal chemotherapy for ovarian cancer: 2009 goals.
Gynecol Oncol. 2009;112:439-40.
PubMed Text format Related articles

ENGLE DB , Belisle JA, Gubbels JA, Petrie SE, et al
Effect of acetyl-l-carnitine on ovarian cancer cells' proliferation, nerve growth factor receptor (Trk-A and p75) expression, and the cytotoxic potential of paclitaxel and carboplatin.
Gynecol Oncol. 2009;112:631-6.
PubMed Text format Related articles Abstract available

ZIVANOVIC O , Leitao MM Jr, Park KJ, Zhao H, et al
Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy.
Gynecol Oncol. 2009;112:590-3.
PubMed Text format Related articles Abstract available

RYU HS
Asian Society of Gynecologic Oncology (ASGO): A new society for doctors working against gynecologic cancers in Asia.
Gynecol Oncol. 2009;112:442-3.
PubMed Text format Related articles

February 2009

KEHOE SM , Williams NL, Yakubu R, Levine DA, et al
Incidence of intestinal obstruction following intraperitoneal chemotherapy for ovarian tubal and peritoneal malignancies.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

ALVAREZ EA , Wolfson AH, Pearson JM, Crisp MP, et al
A phase I study of docetaxel as a radio-sensitizer for locally advanced squamous cell cervical cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

OLAWAIYE AB , Boruta D
Management of women with clear cell endometrial cancer A Society of Gynecologic Oncology (SGO) review.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

JACOBSON G , Lammli J, Zamba G, Hua L, et al
Thromboembolic events in patients with cervical carcinoma: Incidence and effect on survival.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

PERSSON J , Reynisson P, Borgfeldt C, Kannisto P, et al
Robot assisted laparoscopic radical hysterectomy and pelvic lymphadenectomy with short and long term morbidity data.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

LOWE MP , Chamberlain DH, Kamelle SA, Johnson PR, et al
A multi-institutional experience with robotic-assisted radical hysterectomy for early stage cervical cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

KUMAR S , Shah JP, Bryant CS, Awonuga AO, et al
Second neoplasms in survivors of endometrial cancer: Impact of radiation therapy.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

GHEZZI F , Cromi A, Siesto G, Zefiro F, et al
Microlaparoscopy: A further development of minimally invasive surgery for endometrial cancer staging - Initial experience.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

LEFFERS N , Gooden MJ, Mokhova AA, Kast WM, et al
Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

ARGENTA PA , Thomas SG, Judson PL, Downs LS Jr, et al
A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

BOREN T , Xiong Y, Hakam A, Wenham R, et al
MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

YAMADA T , Mori H, Kanemura M, Ohmichi M, et al
Endometrial carcinoma with choriocarcinomatous differentiation: A case report and review of the literature.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

ABU-RUSTUM NR , Khoury-Collado F, Pandit-Taskar N, Soslow RA, et al
Sentinel lymph node mapping for grade 1 endometrial cancer: Is it the answer to the surgical staging dilemma?
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

PERRONE AM , Meriggiola MC, Pelusi G
Sentinel node of endometrial cancer after hysteroscopic injection.
Gynecol Oncol. 2009.
PubMed Text format Related articles

FREDERICK PJ , Straughn JM Jr, Alvarez RD, Buchsbaum DJ, et al
Preclinical studies and clinical utilization of monoclonal antibodies in epithelial ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

KURTZ JE , Hardy-Bessard AC, Deslandres M, Lavau-Denes S, et al
Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trial.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

DAVID MP , Van Herck K, Hardt K, Tibaldi F, et al
Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: Modeling of sustained antibody responses.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

HAVRILESKY LJ , Broadwater G, Davis DM, Nolte KC, et al
Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

CANNON GM , Geye H, Terakedis BE, Kushner DM, et al
Outcomes following surgery and adjuvant radiation in stage II endometrial adenocarcinoma.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

TAKAHASHI A , Kato K, Kuboyama A, Inoue T, et al
Induction of senescence by progesterone receptor-B activation in response to cAMP in ovarian cancer cells.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

KIM HS , Kim MK, Chung HH, Kim JW, et al
Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: A Korean population-based study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

BERRY E , Matthews KS, Singh DK, Buttin BM, et al
An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

ASHTON KA , Proietto A, Otton G, Symonds I, et al
Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

KLASA-MAZURKIEWICZ D , Narkiewicz J, Milczek T, Lipinska B, et al
Maspin overexpression correlates with positive response to primary chemotherapy in ovarian cancer patients.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

STEHMAN FB , Ali S, Disaia PJ
Node count and groin recurrence in early vulvar cancer: A Gynecologic Oncology Group study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

Abstracts presented for the 40th Annual Meeting of the Society of Gynecologic Oncologists,San Antonio, Texas, USA,05-08 February 2009.
Gynecol Oncol. 2009;112.
PubMed Text format Related articles

NEPHEW KP
What will it take to obtain DNA methylation markers for early cervical cancer detection?
Gynecol Oncol. 2009;112:291-2.
PubMed Text format Related articles

MATULONIS UA , Krag KJ, Krasner CN, Atkinson T, et al
Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Mullerian tumors.
Gynecol Oncol. 2009;112:394-9.
PubMed Text format Related articles Abstract available

January 2009

ONDA T , Kobayashi H, Nakanishi T, Hatae M, et al
Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

YANG XY , Xi MR, Yang KX, Yu H, et al
Prognostic value of estrogen receptor and progesterone receptor status in Chinese young ovarian carcinoma patients.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MICHELSEN TM , Dorum A, Dahl AA
A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MARKMAN M
Hyperthermic intraperitoneal chemotherapy in the management of ovarian cancer: A critical need for an evidence-based evaluation.
Gynecol Oncol. 2009.
PubMed Text format Related articles

MAGRINA JF , Kho R, Magtibay PM
Robotic radical hysterectomy: Technical aspects.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

GREVING JP , Vernooij F, Heintz AP, van der Graaf Y, et al
Is centralization of ovarian cancer care warranted? A cost-effectiveness analysis.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

CHIVA LM , Lapuente F, Nunez C, Ramirez PT, et al
Ileal orthotopic neobladder after pelvic exenteration for cervical cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

PARK JY , Kim DY, Kim JH, Kim YM, et al
Surgical management of borderline ovarian tumors: The role of fertility-sparing surgery.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

QUINN JE , Carser JE, James CR, Kennedy RD, et al
BRCA1 and implications for response to chemotherapy in ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SEAMON LG , Cohn DE, Henretta MS, Kim KH, et al
Minimally invasive comprehensive surgical staging for endometrial cancer: Robotics or laparoscopy?
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

LEITAO MM JR , Kehoe S, Barakat RR, Alektiar K, et al
Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

LECURU F , Bats AS, Faraggi M
Sentinel node of endometrial cancer after hysteroscopic injection.
Gynecol Oncol. 2009.
PubMed Text format Related articles

BROWN J , Sood AK, Deavers MT, Milojevic L, et al
Patterns of metastasis in sex cord-stromal tumors of the ovary: Can routine staging lymphadenectomy be omitted?
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SCHILDER RJ , Pathak HB, Lokshin AE, Holloway RW, et al
Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

PIERLUIGI BP , Stefano B, Roberto A
Pelvic and aortic lymphadenectomy in cervical cancer: The standardization of surgical procedure and its clinical impact.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

BEERMAN H , van Dorst EB, Kuenen-Boumeester V, Hogendoorn PC, et al
Superior performance of liquid-based versus conventional cytology in a population-based cervical cancer screening program.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

HOYER PB , Davis JR, Bedrnicek JB, Marion SL, et al
Ovarian neoplasm development by 7,12-dimethylbenz[a]anthracene (DMBA) in a chemically-induced rat model of ovarian failure.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

BIJEN CB , de Bock GH, Mourits MJ
Total laparoscopic hysterectomy versus abdominal hysterectomy with lymphadenectomy for early-stage endometrial cancer: A prospective randomized study.
Gynecol Oncol. 2009.
PubMed Text format Related articles

LEE YK , Park NH
Prognostic value and clinicopathological significance of p53 and PTEN in epithelial ovarian cancers.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

FULHAM MJ , Carter J, Baldey A, Hicks RJ, et al
The impact of PET-CT in suspected recurrent ovarian cancer: A prospective multi-centre study as part of the Australian PET Data Collection Project.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

HEUBNER M , Riemann K, Otterbach F, Kimmig R, et al
The haplotype of two FSHR polymorphisms in ovarian cancer- A potential role of ethnology in risk modification.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MCLEAN K , Vandeven NA, Sorenson DR, Daudi S, et al
The HIV protease inhibitor saquinavir induces endoplasmic reticulum stress, autophagy, and apoptosis in ovarian cancer cells.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

WATTS LA , Joseph N, Wallace M, Rauh-Hain JA, et al
HPV vaccine: A comparison of attitudes and behavioral perspectives between Latino and non-Latino women.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

NEUBAUER NL , Havrilesky LJ, Calingaert B, Bulusu A, et al
The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinoma.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

FANG CY , Cherry C, Devarajan K, Li T, et al
A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MABROUK M , Frumovitz M, Greer M, Sharma S, et al
Trends in laparoscopic and robotic surgery among gynecologic oncologists: A survey update.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

MARKMAN M
"A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer"
Gynecol Oncol. 2009.
PubMed Text format Related articles

TIERSTEN AD , Liu PY, Smith HO, Wilczynski SP, et al
Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

VERNOOIJ F , Heintz AP, Coebergh JW, Massuger LF, et al
Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in The Netherlands.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

FEHM T , Beck V, Banys M, Lipp HP, et al
Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

RUBATT JM , Darcy KM, Hutson A, Bean SM, et al
Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

BIJEN CB , de Bock GH, Ten Hoor KA, Nijman HW, et al
Role of endocervical curettage in the preoperative staging of endometrial carcinoma.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SHIELD K , Ackland ML, Ahmed N, Rice GE, et al
Multicellular spheroids in ovarian cancer metastases: Biology and pathology.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

CHIN SN , Pinto V, Rosen B, Oza A, et al
Evaluation of an intraperitoneal chemotherapy program implemented at the Princess Margaret Hospital for patients with epithelial ovarian carcinoma.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

HENSLEY ML , Ishill N, Soslow R, Larkin J, et al
Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

FOWLER JM , Brady WE, Grigsby PW, Cohn DE, et al
Sequential chemotherapy and irradiation in advanced stage endometrial cancer: A gynecologic oncology group phase I trial of doxorubicin-cisplatin followed by whole abdomen irradiation.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

SHETH RA , Upadhyay R, Stangenberg L, Sheth R, et al
Improved detection of ovarian cancer metastases by intraoperative quantitative fluorescence protease imaging in a pre-clinical model.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

OLAWAIYE A , Del Carmen M, Tambouret R, Goodman A, et al
Abdominal radical trachelectomy: Success and pitfalls in a general gynecologic oncology practice.
Gynecol Oncol. 2009.
PubMed Text format Related articles Abstract available

November 2008

MENNINI FS , Giorgi Rossi P, Palazzo F, Largeron N, et al
Health and economic impact associated with a quadrivalent HPV vaccine in Italy.
Gynecol Oncol. 2008.
PubMed Text format Related articles Abstract available

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.
Design: